Instead of Filling Cavities, Dentists May Soon Regenerate Teeth - DiscoveryCampus
12686
post-template-default,single,single-post,postid-12686,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-2.6,wpb-js-composer js-comp-ver-5.4.5,vc_responsive

Instead of Filling Cavities, Dentists May Soon Regenerate Teeth

Instead of Filling Cavities, Dentists May Soon Regenerate Teeth

20:13 01 February in Uncategorized
0 Comments

For dentists, a cavity is a conundrum—in order to save the tooth they must further damage it. Currently, the primary way to treat a cavity is to excavate the decay and the surrounding area before filling the resulting crater with a durable surrogate material such as metal, plastic or glass cement.

But what if instead of drilling holes into teeth and patching them up with synthetic fillers, dentists could coax our pearly whites to regrow themselves? Recently, Paul Sharpe, a bioengineer at King’s College London, and his colleagues discovered a new way to do exactly this in mice. Last year they published a study describing their innovative techniques in Scientific Reports. And since then they have made even more progress that edges this experimental procedure closer to human clinical trials. If the treatment eventually becomes part of the dentist’s standard tool kit, scientists say it would easily be one of the field’s most important advances in 50 years.

Our teeth get damaged all the time. Most of the injuries they endure are due to everyday wear and tear as well as the activity of microbes in the mouth. These organisms coat the surface of each tooth and feed on meal remnants. As they break down particles of food, some of these microbes produce and secrete acids as a by-product. And that acidity degrades enamel—the tooth’s hard outer layer.

Like skin, teeth can usually repair minor mishaps themselves. When our teeth remain uncleaned for too long, however, acid can eat through the enamel and begin dissolving underlying layers of dense, bony tissue called dentin. When dentin is seriously injured, stem cells located in the tooth’s soft, innermost layer—the dental pulp—morph into cells called odontoblasts, which secrete new tissue. (Stem cells are capable of becoming virtually any type of cell.) Yet when the injury is too large or deep, that fresh dentin is not sufficient to restore the tooth. The result is often a cavity.

Sharpe suspected he could dramatically boost teeth’s natural healing ability by mobilizing stem cells in the dental pulp. Earlier research had demonstrated the Wnt signaling pathway—a particular cascade of molecules involved in cell-to-cell communication—is essential for tissue repair and stem cell development in many parts of the body such as the skin, intestines and brain. Sharpe wondered: Could this signaling pathway also be important for self-repair processes in teeth? If so, maybe exposing damaged teeth to drugs that stimulate Wnt signaling would similarly encourage the activity of stem cells in the dental pulp—giving teeth the kind of regenerative superpowers usually seen only in plants, salamanders and starfish.

To test this idea, Sharpe and his fellow researchers drilled holes into the molars of mice, mimicking cavities. They then soaked tiny collagen sponges (which are made from the same protein found in dentin) in various drugs known to stimulate Wnt signaling, including tideglusib, a compound that has been investigated in clinical trials for its potential to treat Alzheimer’s and other neurological disorders. The scientists then placed these drug-soaked sponges in the drilled mouse molars, sealed them up and left them for four to six weeks. The teeth treated with these drugs produced significantly more dentin than ones untreated or stuffed with an unsoaked sponge or typical dental fillers. In most cases the technique restored the rodents’ pearly whites to their former intact state. “It was essentially a complete repair,” Sharpe says. “You can barely see the joint where the old and new dentin meet. This could eventually be the first routine pharmaceutical treatment in dentistry.”

David Mooney, a professor or bioengineering at Harvard University who has also investigated new ways to heal teeth but was not involved in the study, says he is “very impressed” by these findings. “This is not just scientifically important, but has significant practical advantages,” he says. Adam Celiz, an assistant professor of bioengineering at Imperial College London who was also not involved in the recent research, says this is an important advance in the emerging field of regenerative dentistry. “The materials dentists use could soon be revolutionized,” he says.

Any treatment that recruits the body’s native stem cells or adds new stems cells to the body, however, poses a risk of uncontrolled tissue growth. Experimental and unregulated stem cell therapies have resulted in brain tumors, for example, as well as bones growing in eyelids. But in this case, Sharpe says, the amounts of drug used are so tiny that the risk of unwanted growth is minimal. Celiz agrees the danger is small but he says rigorous testing in lab animals and clinical trials should be done to rule out potential side effects.

Since publishing their initial study Sharpe and his colleagues have tested their regenerative technique on rats. (Because those rodents have larger teeth than mice, a drilled rat molar better approximates human tooth decay.) The treatment worked just as well on the rats as it had on the mice, Sharpe says, but the data has not yet been published. Now Sharpe’s team is investigating a larger group of candidate drugs in order to determine whether another medication works better than those already tested, and to determine the optimal dose. They are also developing an alternative delivery system that is more amenable to modern dental practices: The chosen drug will be dissolved in a gel that is injected into a cavity and bathed with ultraviolet light to solidify it—a quick and easy procedure similar to one dentists already use to seal and repair teeth.

In order to formally introduce this treatment to modern dentistry, however, the researchers will need to perform clinical trials with human patients. Such work is at least several years away, Sharpe says. But some of the drugs he might consider are already approved for other uses in humans, which he hopes could expedite the process for eventual approval. “A lot of dental treatments are still in the dark ages,” Sharpe says. “It’s time to move on.”


Source link

asdasd asda

hiya54@live.ca
No Comments

Sorry, the comment form is closed at this time.